Medtronic receives CE Mark for updated MRI pacemaker
Medtronic has received the European CE Mark for its second-generation pacemaker for use with MRI machines, the Advisa DR MRI SureScan pacing system.
The company said its Advisa MRI SureScan pacing system combines MRI SureScan with features from Medtronic pacemakers and defibrillator systems such as managed ventricular pacing, OptiVol fluid status monitoring and ventricular and atrial capture management (VCM and ACM).
VCM and ACM are intended to adjust impulses for optimal stimulation of the heart's chambers, according to the Minneapolis-based Medtronic.
]
The device also offers enhanced diagnostics to help assist physicians in the diagnosis of irregular heart rhythms, particularly atrial tachyarrhythmia/atrial fibrillation. Additionally, upon commercial release, the Advisa MRI SureScan pacing system will be available for remote follow-up via the Medtronic CareLink Network.
The Advisa MRI SureScan pacing system currently is not available for sale in the U.S.
The company said its Advisa MRI SureScan pacing system combines MRI SureScan with features from Medtronic pacemakers and defibrillator systems such as managed ventricular pacing, OptiVol fluid status monitoring and ventricular and atrial capture management (VCM and ACM).
VCM and ACM are intended to adjust impulses for optimal stimulation of the heart's chambers, according to the Minneapolis-based Medtronic.
]
The device also offers enhanced diagnostics to help assist physicians in the diagnosis of irregular heart rhythms, particularly atrial tachyarrhythmia/atrial fibrillation. Additionally, upon commercial release, the Advisa MRI SureScan pacing system will be available for remote follow-up via the Medtronic CareLink Network.
The Advisa MRI SureScan pacing system currently is not available for sale in the U.S.